ArticleHemaSphere2026

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML.

Warren Fiskus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.